Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis

Molecular Pharmacology

Volumn 71, Issue 4, 2007, Pages 965-975

  Jin, Hee Shin ^a   Sung, Ig Cho ^a   Hyang, Ran Lim ^a   Jae, Keun Lee ^a   Young, Ae Lee ^a   Jai, Sung Noh ^a   In, Soo Joo ^a   Kim, Kee Won ^b   Byoung, Joo Gwag ^a  

^a Ajou University School of Medicine   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 5 (2,3,5,6 TETRAFLUORO 4 TRIFLUOROMETHYL BENZYLAMINO BENZOIC ACID; ANTIOXIDANT; CASPASE 3; CASPASE 8; FAS ANTIGEN; LITHIUM CARBONATE; NEU2000; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; MORTALITY; MOTONEURON; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; BENZOIC ACIDS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; LITHIUM CARBONATE; MICE; MORTALITY; MOTOR ACTIVITY; MOTOR NEURONS; OXIDATIVE STRESS;

EID: 33947363215     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.030676     Document Type: Article

References (45)

1. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, and Brown RH Jr (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42:644-654.
2. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, and Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162-7166.
3. Bowling AC, Schulz JB, Brown RH Jr, and Beal MF (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 61:2322-2325.
4. Chalecka-Franaszek E and Chuang DM (1999) Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96:8745-8750.
5. Chuang DM (2005) The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann NY Acad Sci 1053:195-204.
6. Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS, Mitchell JD, and Lynch PG (1996) Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19:797-798.
7. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, and Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 158:100-106.
8. Guegan C, Vila M, Rosoklija G, Hays AP, and Przedborski S (2001) Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21:6569-6576.
9. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, and Hall ED (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39:147-157.
10. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (Wash DC) 264:1772-1775.
11. Gwag BJ, Koh JY, DeMaro JA, Ying HS, Jacquin M, and Choi DW (1997) Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77:393-401.
12. Gwag BJ, Lee YA, Ko SY, Lee MJ, Im DS, Yun BS, Lim HR, Park SM, Byun HY, Son SJ, et al. (2006) Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J Cerebr Blood F Met, in press. doi: 10.1038/sj.jcbfm.9600418
13. Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, Nagao M, Kawata A, Saido TC, Miura M, et al. (2003) The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO (Eur Mol Biol Organ) J 22:6665-6674.
14. Kang HJ, Noh JS, Bae YS, and Gwag BJ (2003) Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cγ. Mol Pharmacol 64:228-234.
15. Kaspar BK, Llado J, Sherkat N, Rothstein JD, and Gage FH (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (Wash DC) 301:839-842.
16. Kim DY, Won SJ, and Gwag BJ (2002) Analysis of mitochondrial free radical generation in animal models of neuronal disease. Free Radic Biol Med 33:715-723.
17. Kim SH, Won SJ, Sohn S, Kwon HJ, Lee JY, Park JH, and Gwag BJ (2002) Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase. J Cell Biol 159:821-831.
18. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, and Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
19. Koh JY, Gwag BJ, Lobner D, and Choi DW (1995) Potentiated necrosis of cultured cortical neurons by neurotrophins. Science (Wash DC) 268:573-575.
20. Kong J and Xu Z (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18:3241-3250.
21. Kostic V, Jackson-Lewis V, de BF, Dubois-Dauphin M, and Przedborski S (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science (Wash DC) 277:559-562.
22. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee JP, Przedborski S, et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (Wash DC) 288:335-339.
23. Liu R, Althaus JS, Ellerbrock BR, Becker DA, and Gurney ME (1998) Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 44:763-770.
24. Luchsinger JA, Tang MX, Shea S, and Mayeux R (2003) Antioxidant vitamin intake and risk of alzheimer disease. Arch Neurol 60:203-208.
25. Martin LJ (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 58:459-471.
26. Martin VA, Hahne M, Kleber S, Vogel J, Falk W, Schenkel J, and Krammer PH (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 8:679-686.
27. Matthews RT, Yang L, Browne S, Baik M, and Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 95:8892-8897.
28. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, and White LR (1996) Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 46:1270-1274.
29. Mu X, He J, Anderson DW, Trojanowski JQ, and Springer JE (1996) Altered expression of Bcl-2 and Bax MRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 40:379-386.
30. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, and Brown RH Jr (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43:19-30.
31. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, and Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824.
32. Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, and Beal MF (2006) Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 22:40-49.
33. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, and Pettmann B (2002) Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-1083.
34. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in Nature (Lond) 364:362, 1993]. Nature (Lond) 362:59-62.
35. Ross JB and Frank IT (2001) Drugs and the treatment of psychiatric disorders, The Pharmacological Basis of Therapeutics (Joel GH and Lee EL, eds) pp. 508-512, The McGraw-Hill Co.
36. Ryu BR, Ko HW, Jou I, Noh JS, and Gwag BJ (1999) Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol 39:536-546.
37. Senatorov VV, Ren M, Kanai H, Wei H, and Chuang DM (2004) Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol Psychiatry 9:371-385.
38. Su JH, Anderson AJ, Cribbs DH, Tu C, Tong L, Kesslack P, and Cotman CW (2003) Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis 12:182-193.
39. Vukosavic S, Dubois-Dauphin M, Romero N, and Przedborski S (1999) Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 73:2460-2468.
40. Williams TL, Day NC, Ince PG, Kamboj RK, and Shaw PJ (1997) Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 42:200-207.
41. Won SJ, Park EC, Ryu BR, Ko HW, Sohn S, Kwon HJ, and Gwag BJ (2000) NT-4/5 exacerbates free radical-induced neuronal necrosis in vitro and in vivo. Neurobiol Dis 7:251-259.
42. Xu J, Culman J, Blume A, Brecht S, and Gohlke P (2003) Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 34:1287-1292.
43. Youdim MB and Arraf Z (2004) Prevention of MPTP (N-methyl-4- phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax. Neuropharmacology 46:1130-1140.
44. Zhang W, Narayanan M, and Friedlander RM (2003) Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann Neurol 53:267-270.
45. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu d C, et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature (Lond) 417:74-78.